Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 12 2018

Full Issue

Senate Poised To Vote On Massive Opioid Package, But Advocates Still Say It Doesn't Do Enough

Although the vote will likely give lawmakers running for re-election in states hit hard by the epidemic a talking point, enough differences remain between the Senate and House versions that there's still a lot of work to be done before it gets to the president to sign. And advocates are disappointed with what didn't make it in the legislation. Meanwhile, Purdue is offering free addiction treatment medication as part of its efforts to settle the flood of lawsuits it is facing.

Stat: What’s In The Senate’s Opioid Package — And What's Not 

The Senate will vote this week on a bill to prevent illicit fentanyl trafficking, account for drug diversion in opioid manufacturing quotas, and improve access to addiction treatments via telemedicine. Many senators, soon to campaign for re-election in states hard-hit by the epidemic, say the bill is enough. Many advocates for better addiction treatment beg to differ. (Facher, 9/12)

Bloomberg: Purdue Pharma Is Offering Free Opioid Treatment In Legal Talks

The company that created OxyContin is offering free doses of an opioid-abuse treatment as part of its offer to resolve more than 1,000 lawsuits accusing the drugmaker of helping fuel the opioid crisis, according to people familiar with the negotiations. Purdue Pharma has repeatedly said it will give away doses of a new version of buprenorphine -- which helps wean people addicted to opioids off the drugs -- as part of any settlement, according to four people familiar with the talks sponsored by state attorneys general and a federal judge. They asked not to be cited by name as the negotiations are confidential. (Hopkins and Feeley, 9/11)

In other news on the crisis —

NPR: 'Recovery Houses' Often Won't Let Residents Use Methadone

Cristina Rivell has been struggling with an opioid addiction since she was a teenager — going in and out of rehab for five years. The most recent time, her doctor prescribed her a low dose of buprenorphine (often known by its brand name, Suboxone), a drug that helps curb cravings for stronger opioids and prevents the symptoms of withdrawal. (Feldman, 9/12)

Houston Chronicle: Insurers Take Aim At Opioid Crisis By Not Covering OxyContin 

Private insurers across the country and in Texas have entered the very public fight against opioid addiction, with some now outright denying coverage of OxyContin, the most notorious of drugs linked to the crisis. But the move has unleashed a clash of opinion over its wisdom, with the insurance industry defending the crackdown as an important deterrent while some in Houston’s drug abuse treatment and pain management communities call it an over-reaction and question the effectiveness of taking a stand against one drug. (Deam, 9/11)

The Associated Press: Officials Report Record Number Of Overdose Deaths In August

Delaware public health officials are reporting a record number of deaths from suspected drug overdoses in August. Officials said Tuesday that the 39 deaths reported last month is the highest since they began tracking deaths from suspected overdoses in late 2013. The previous monthly high was 27 deaths in April. Officials suspect many of the overdoses involved fentanyl, a highly toxic synthetic opioid far more potent than heroin. (9/11)

New Hampshire Public Radio: Plymouth State University Receives Grant To Train Students On Treating Opioid Use

Plymouth State University has received a grant from the federal government to train its clinical mental health students in treating substance abuse. The $400,000 will go towards two things: paying students a $10,000 stipend when they intern at a partner health center, and providing training and conference funding for students and faculty. (Allee, 9/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF